Proton Therapy Australia Pty Ltd

07/03/2026

https://www.aol.com/articles/millisecond-could-change-cancer-treatment-140003204.html

Inside a cavernous hall at the Swiss-French border, the air hums with high voltage and possibility. From his perch on the wraparound observation deck, physicist Walter Wuensch surveys a multimillion-dollar array of accelerating cavities, klystrons, modulators, and pulse compressors—hardware being ...

05/03/2026

https://www.cureus.com/abstracts/1637-initial-outcomes-of-patients-undergoing-proton-re-irradiation-after-definitive-prostate-radiotherapy

Objectives: Patients presenting with local failure after definitive radiation therapy for prostate cancer have historically been treated with hormonal/systemic therapy. Local options, such as salvage prostatectomy, have been associated with higher morbidity, whereas HIFU and cryotherapy have limited...

14/02/2026

https://www.curetoday.com/view/proton-therapy-improves-survival-in-patients-with-lower-grade-glioma

Phase 2 study shows proton therapy kept 79.1% of patients progression free at five years and limited severe side effects compared with older radiation data.

17/01/2026

https://www.linkedin.com/posts/susannebleasel_oslo-university-hospital-pioneered-proton-activity-7418147145180053504-YpVL?utm_medium=ios_app&rcm=ACoAAADkTf0BYk_LirviU1BBbRoZb1TWx-0cRUA&utm_source=social_share_send&utm_campaign=facebook

14/01/2026

https://c.org/SkvJYhCtzp

Australians Need Proton Therapy Here at Home

02/01/2026

Eight studies comprising 310 patients (247 receiving PT) were included. Tumor types varied and included gliomas, meningiomas, craniopharyngiomas, and others. Overall, PT was associated with stable or improved outcomes in global cognition, memory, language, executive function, attention, working memory, and visuospatial abilities. No study reported progressive cognitive decline.

Intracranial neoplasms are abnormal cell growths within the central nervous system (CNS) that may lead to neuropsychological dysfunction due to their location, mass effect, and proximity to eloquent brain regions. They represent 1,6% of all tumors …

18/11/2025

WORLD LEADERS - IN PROTON THERAPY

Our mission is not only to treat cancer with one of the most promising methods of the 21st century - proton therapy, but above all provide patients with outs...

23/10/2025

"We would need to deliver 45 to 50 treatments of IMRT to give the same biologic equivalent dose we achieve with five sessions of proton therapy," says Dr. Vargas. "This means we are able to deliver a higher biologic dose against the cancer than possible with traditional radiation."

Mayo Clinic's phase 3 clinical trial shows higher doses of proton therapy delivered over fewer sessions can be just as effective as longer radiation therapy.

17/10/2025

An excellent presentation.
PTA taking note.

Prof. Barbara Alicja Jereczek-Fossa, Chair of Radiation Oncology at the European Institute of Oncology (IEO) in Milan, Italy, full Professor at the Universit...

26/09/2025

MD Anderson insights: “The investigation of actionable biomarkers is one of the most important frontiers in prostate cancer.

10/09/2025

https://www.linkedin.com/posts/protontherapy-academy_protontherapyacademy-clinicaltraining-medicaleducation-activity-7371501277744365568-bQn1?utm_medium=ios_app&rcm=ACoAAADkTf0BYk_LirviU1BBbRoZb1TWx-0cRUA&utm_source=social_share_video_v2&utm_campaign=facebook

05/09/2025

Proton Therapy Australia is committed to bringing world-class cancer care to Sydney through the development of a proton therapy centre in Alexandria. This facility aligns with the Government’s vision for multiple proton centres across the country and will be funded entirely by private capital.

More than 9,000 Australians each year could benefit from proton therapy. Even if the SAHMRI/Bragg Centre proceeds, which we hope will be the case, demand will require both Adelaide and Sydney facilities to ensure patients are treated at home rather than overseas. It is essential that children and adults with the 13 cancers already approved by MSAC — and with further indications such as left-sided breast, oesophageal, and head and neck cancers now in the pipeline — have timely access to care in Australia.

“We’ve got a lot of work to do collectively to make our economy more productive” - Treasurer Jim Chalmers Australian Productivity Summit August 2025.
“This data shows that the much needed ‘handover’ from the public to private sector as our primary engine of growth has yet to properly occur.”

With final MBS approval of the 13 indications already endorsed by MSAC, Proton Therapy Australia’s Sydney centre can move ahead immediately. We invite Government, clinicians, and investors to work with us to ensure Australians have timely access to this vital treatment, delivered through a sustainable partnership between private capital and public health priorities.